The question of whether lowering cortisol is useful for blood sugar control requires a nuanced, evidence-aware answer. Cortisol is a glucocorticoid that promotes gluconeogenesis and impairs insulin sensitivity; chronically elevated levels are associated with hyperglycemia and metabolic syndrome. However, direct interventions to lower cortisol—such as supplements like ashwagandha, phosphatidylserine, or magnesium—have limited and inconsistent evidence for improving glycemic outcomes in non-clinical populations. Most studies are small, short-term, or lack proper controls. Lifestyle strategies (sleep optimization, moderate exercise, stress management) have stronger support for reducing cortisol and improving blood sugar, but the effect size is modest. Importantly, lowering cortisol in individuals with normal levels may not provide benefit and could even be counterproductive, as cortisol is essential for daily function. Consumer tests (DNA, blood spot) from MyBody-X do not measure cortisol directly and are not validated for guiding cortisol-lowering interventions. Evidence grade: mixed—mechanistic plausibility exists, but clinical proof for routine use is lacking. Caveat: do not self-treat with cortisol-lowering supplements without medical supervision, especially if you have diabetes or adrenal issues.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-daa0b929725feed3e4022266